hkex report

HKEX-LD138-2022 (September 2022) Summary. Parties. Company A to Company E – each a proposed applicant seeking listing on the Main Board with a Weighted Voting Rights (WVR)

2022 ; Date. Aug 28, 2022 ; Item. Letter to Non-registered Shareholder - Notification of Publication of 2022 Half Year Financial Report ; HKEx (English), pdf ; HKEx 

View Publications by Predefined Documents. Shareholding Disclosures. Disclosure of Interests. CCASS Shareholding Search. Stock Connect Shareholding Search. New Listings. Application Proof, OC Announcements, PHIP and Related Materials. New Listing Information. Progress Report for New Listing Applications.

Listing Policy Panel Report. Rules and Guidance. Listing Rules. Interpretation and Guidance. Corporate Governance Practices. Listing of Overseas Companies. Listing of Biotech

The exchange went from 20 new listings last year to only four this year. The aggregate market capitalization of all Hong Kong-listed biotech companies was almost USD 119 billion at the end of – compared to around USD 90 billion the previous year, according to this report from Skadden.

HKEX is the world's leading IPO market and as Hong Kong's only securities and derivatives exchange and sole operator of its clearing houses, it is uniquely placed to offer regional and international investors access to Asia's most vibrant market. Investor Relations Financial Results and Presentations Financial Results and Presentations Year 2022

HKEx Publishes Results of Latest Review of Annual Report Disclosures its review of issuers' annual reports for the financial year.

CFIUS - ANNUAL REPORT TO CONGRESS - CY viii The Committee on Foreign Investment in the United States Authority and Composition The Committee on Foreign Investment in the United States (CFIUS or the Committee) is an interagency body of the U.S. Government that is authorized by law to review and address national security risks.

Negative Reputation. It has come to our attention that HKEx has a negative reputation. This is based on not only customer reviews but expert reviews, news from regulators, and the press. Any broker can have the occasional dissatisfied client. Someone may not have made enough money on trades and accuse the broker of being a fraud.

Distribution of annual report and accounts (13.46) Annual Reports (13.47) Interim Reports (13.48) 13.48 Preliminary Announcements of Results — Full Financial Year (13.49) Suspension on Failure to Publish Timely Financial Information (13.50 to 13.50B) Notification Announcements, Circulars and Other Documents Trading and Settlement General

HKEX is the world's leading IPO market and as Hong Kong's only securities and derivatives exchange and sole operator of its clearing houses, it is uniquely placed to offer regional and international investors access to Asia's most vibrant market. Investor Relations Financial Results and Presentations Financial Results and Presentations Year 2022